Breaking news

Nvidia Unleashes Evo 2: The AI Powerhouse For Genetic Research

by THEFUTURE.TEAM

February 20, 2025

Nvidia, the U.S.-based AI chip giant, has unveiled Evo 2, the most advanced artificial intelligence system dedicated to biomolecular science. Built-in collaboration with Stanford University and the nonprofit Arc Institute, Evo 2 is set to redefine genetic research, accelerating breakthroughs in medicine and biotechnology.

AI Meets Genomics

Powered by Nvidia DGX Cloud on Amazon Web Services (AWS), Evo 2 is designed to decode the complexities of DNA, RNA, and proteins across a vast spectrum of species. With a dataset of nearly 9 trillion nucleotides—the fundamental units of DNA and RNA—this AI model is poised to revolutionize biological research. Its capabilities extend to predicting protein structures, identifying novel molecules for healthcare and industrial applications, and analyzing the effects of genetic mutations.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Evo 2 is now the largest publicly available AI model for genomic data, offering scientists an unprecedented tool for biological discovery. Researchers can leverage Nvidia’s NIM microservice to generate biological sequences and fine-tune the model using their proprietary datasets via the open-source Nvidia BioNeMo Framework.

Game-Changing Potential

“Evo 2 represents a major milestone for generative genomics,” said Patrick Hsu, cofounder of Arc Institute and assistant professor of bioengineering at UC Berkeley. “By deepening our understanding of life’s fundamental building blocks, we can unlock new possibilities in healthcare and environmental science that were once unimaginable.”

Brian Hie, assistant professor of chemical engineering at Stanford and faculty fellow at the Dieter Schwarz Foundation Stanford Data Science, echoed this sentiment: “With Evo 2, complex biological design becomes more accessible, allowing researchers to develop groundbreaking innovations in a fraction of the time.”

Market Reaction

Despite the breakthrough, Nvidia’s stock dipped 0.2% in after-hours trading on Wednesday, settling at $139 per share, with a market capitalization of $3.4 trillion. However, as AI-driven biotech advances continue to gain momentum, Nvidia’s role in shaping the future of medicine and genomics remains stronger than ever.

The Future Forbes Realty Global Properties

EBA Finds Gaps In Bank Recovery Dry Run Practices

by THEFUTURE.TEAM

April 15, 2026

Overview Of The European Banking Authority Findings

The European Banking Authority (EBA) published a report examining how banks conduct dry runs to test recovery plans. The analysis focuses on how institutions prepare for stress scenarios and assess their ability to implement recovery measures. Dry runs serve as practical tests of operational readiness under adverse conditions.

Varied Approaches And Institutional Maturity

Findings show clear differences in how banks design and execute these exercises. Approaches vary in scope, methodology, and depth of implementation. Institutions that treat dry runs mainly as compliance exercises tend to gain limited practical value. In such cases, testing does not translate into improvements in recovery planning.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Integrating Dry Runs Into Broader Risk Management

More advanced institutions integrate dry runs into broader risk management processes. These exercises are used to test internal coordination, decision-making, and operational response. Such integration improves the feasibility of recovery plans and supports faster execution during stress events.

Regulatory Evolution And Future Implications

The EBA highlights the need for consistent and high-quality testing of recovery frameworks. Updates to testing approaches are required as risk conditions evolve. Closer alignment between recovery and resolution planning is also identified as an area for further development.

Moving Forward With Strategic Preparedness

According to EBA, the benchmarking exercise is intended to guide improvements rather than impose requirements. The report provides reference points for strengthening testing practices across institutions. Additional guidance, including the EBA handbook on simulation exercises, supports further development of recovery and resolution planning.